{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:23:35Z","timestamp":1790022215576,"version":"4.0.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"crossref","award":["2015SZ0152"],"award-info":[{"award-number":["2015SZ0152"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">Stenotrophomonas maltophilia<\/jats:italic> (<jats:italic toggle=\"yes\">S. maltophilia<\/jats:italic>) is an important nosocomial bacterial pathogen. However, the clinical features of children with <jats:italic toggle=\"yes\">S. maltophilia<\/jats:italic> infection, the predisposing factors, and the antibiotic susceptibility of the bacteria have not been fully evaluated.<\/jats:p>\n            <jats:p>In this study, the data of children with <jats:italic toggle=\"yes\">S. maltophilia<\/jats:italic> infection from the West China Second University Hospital of Sichuan University (Chengdu, China) between July 2010 and October 2017 were collected and analyzed. The clinical features of enrolled children, the predisposing factors, and the antibiotic susceptibility were reported.<\/jats:p>\n            <jats:p>In total, infection of <jats:italic toggle=\"yes\">S. maltophilia<\/jats:italic> was identified in 128 patients. Most of these patients were under 1 year old (67.2%) and were mainly diagnosed as pneumonia (69%). A large proportion had underlying diseases (45.3%), received immunosuppressive therapy (53.1%), had undergone invasive operations (41.4%), had a history of carbapenem antibiotics use within 7 days before culture acquisition (54.7%), history of intensive care unit (ICU) hospitalization within previous 30 days (34.4%), and other risk factors. In particular, invasive operation (95% confidence interval [CI]: 1.125\u201314.324, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.032), especially mechanical ventilation (95% CI: 1.277\u201320.469, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.021), and ICU admission (95% CI: 1.743\u201322.956, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.005) were independent risk factors for the children to develop severe <jats:italic toggle=\"yes\">S. maltophilia<\/jats:italic> infection. As for antibiotic susceptibility, trimethoprim sulfamethoxazole (TMP-SMX), piperacillin tazobactam, ticarcillin clavulanate, and ceftazidime exhibited strong antibacterial activities against <jats:italic toggle=\"yes\">S. maltophilia,<\/jats:italic> the susceptibility rates were 97.5%, 86.7%, 92.9%, and 81.5%, respectively.<\/jats:p>\n            <jats:p>We report the clinical features of children with <jats:italic toggle=\"yes\">S. maltophilia<\/jats:italic> infection, the predisposing factors and the antibiotic susceptibility. TMP-SMX can continue to be the first choice for the treatment of <jats:italic toggle=\"yes\">S. maltophilia<\/jats:italic> infection. Piperacillin tazobactam, ticarcillin clavulanate, and the third generation cephalosporins can be used as alternative drugs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019250","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T04:53:44Z","timestamp":1582260824000},"page":"e19250","source":"Crossref","is-referenced-by-count":16,"title":["Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017"],"prefix":"10.1097","volume":"99","author":[{"given":"Lili","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, West China Second University Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmin","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,2]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1179\/146532808X302152","article-title":"Stenotrophomonas maltophilia bacteraemia in Turkish children","volume":"28","author":"Guriz","year":"2008","journal-title":"Ann Trop Paediatr"},{"key":"R4-20230915","first-page":"144","article-title":"Stenotrophomonas maltophilia bacteremia in pediatric patients \u2013 a 10-year analysis","volume":"39","author":"Wu","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/ICO.0000000000001486","article-title":"Clinical features, antibiotic susceptibility profile, and outcomes of infectious keratitis caused by Stenotrophomonas maltophilia","volume":"37","author":"Palioura","year":"2018","journal-title":"Cornea"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"e0133731","DOI":"10.1371\/journal.pone.0133731","article-title":"Risk factors associated with Stenotrophomonas maltophilia bacteremia: a matched case-control study","volume":"10","author":"Sumida","year":"2015","journal-title":"PloS One"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jmii.2014.06.005","article-title":"Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: a 10-year retrospective study","volume":"49","author":"Wang","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2169\/internalmedicine.56.6141","article-title":"Clinical characteristics of Stenotrophomonas maltophilia bacteremia: a regional report and a review of a Japanese case series","volume":"56","author":"Ebara","year":"2017","journal-title":"Intern Med"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1093\/cid\/cir1073","article-title":"Laboratory methods for determining pneumonia etiology in children","volume":"54 Suppl 2","author":"Murdoch","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00365549409011780","article-title":"Xanthomonas maltophilia bacteremia in immunocompromised hematological patients","volume":"26","author":"Victor","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12223-010-0043-4","article-title":"Stenotrophomonas maltophilia: significant contemporary hospital pathogen - review","volume":"55","author":"Nyc","year":"2010","journal-title":"Folia Microbiol (Praha)"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/eri.11.24","article-title":"Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment","volume":"9","author":"Abbott","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1055\/s-2007-996414","article-title":"Optimizing therapy for Stenotrophomonas maltophilia","volume":"28","author":"Muder","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3201\/eid1304.061378","article-title":"Global emergence of trimethoprim\/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes","volume":"13","author":"Toleman","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10096-007-0279-3","article-title":"Antimicrobial therapy for Stenotrophomonas maltophilia infections","volume":"26","author":"Nicodemo","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R18-20230915","first-page":"23","article-title":"Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem","volume":"5","author":"Al-Jasser","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/AAC.45.2.413-419.2001","article-title":"Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia","volume":"45","author":"Avison","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/317473","article-title":"Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital","volume":"31","author":"Sattler","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/341022","article-title":"Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients","volume":"35","author":"Hanes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R22-20230915","first-page":"124","article-title":"Analysis of clinical distribution and drug resistance of 1212 strains of Stenotrophomonas maltophilia","volume":"14","author":"Wang","year":"2017","journal-title":"China Med Herald"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:39:44Z","timestamp":1694821184000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019250","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}